Beroni Group

Beroni Group is an international biotechnology company listed on the National Stock Exchange (Australia) and traded in the U.S. over-the-counter market, with operations in Australia, China, Japan, and the United States. It currently has four core businesses: cell therapy, development of new anti-cancer drugs, e-commerce platforms for pharmaceuticals and health products, and detection and diagnosis of infectious diseases. It focuses on the development and commercialization of innovative immune cell therapies and new drugs to meet significant unmet medical needs of cancer patients in China and globally.